Cell Based Assays Market By Product Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cell Based Assays Market
Cell Based Assays Market: By Product Type (Consumables, Instruments, Software & Service) By Application (Drug Discovery, Basic Research, Predictive Toxicology & Other), By End-User (Healthcare, Government & Others) & By Geography-Forecast (2016-2021)
Report Code : HCR 0184
Updated Date: 23 February, 2016   20% discount on this report

  • Report Description
  • Table of Contents
  • Customization Options
Cell based assay is defined as a technique for analysing the living cell on the basis of different parameters. This technology is basically used to measure virtually of cellular or biochemical functions. Functional cells are used as diagnostic tools in research for new drugs in the cell based assays technique. Cell based assays helps in measuring cell proliferations, motility, toxicity, production of a measurable product and morphology in diagnostics and drug discovery. This technique is used by pharmaceutical companies, academic research institutes, biotechnology companies, government institutions, contract research organizations and others. Cell based assays also facilitate research in the area of stem cells, cancer, immunology and others.

This report identifies the cell based assays market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cell based assays market.

Cell Based Assays Market

Globally North America dominated the market for cell based assays in 2015 due to higher increasing R&D activities and penetration of the cell based assays in end-use industry. North America is expected to continue its domination and was followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to technological advancement and increasing R&D activities in life science and drug activities.

This report on global cell based assays also covers different type of cell based assays available, applications of cell based assays, end-user industry and market size in various geographical regions.
  • On the basis of type of cell based assays this report classifies as follows covering all major types of cell based assays available in the market: Consumables (Microplates, Cell Lines, Reagents & Assay Kits and Others), Instruments, Software and Service
  • This report cell based assays market is also segmented on the basis of major end-use applications of cell based assays, some of the major applications oology and Other Applications
  • This reportf cell based assays are: Drug Discovery, Basic Research, Predictive Toxic cell based assays market is also segmented on the basis of major end-use industry of cell based assays, some of the major end-use industry of cell based assays are: Pharmaceutical & Healthcare, Government Institutions and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cell based assays in each of the region.

Sample Companies Profiled in this Report are: 
  • Becton, Dickinson and Company
  • General Electric Company
  • Thermo Fisher Scientific Inc      
  • Cell Signaling Technology, Inc.     
  • Danaher Corporation
  • 10+
1. Cell Based Assays – Market Overview
2. Executive Summary
3. Cell Based Assays Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Cell Based Assays – Market Forces
   4.1. Drivers
      4.1.1. Increasing government initiatives& funding to support and promote R&D
   4.2. Restraints
      4.2.1. High Infrastructure Cost
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Cell Based Assays Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Cell Based Assays Market, By Product Type
   6.1. Consumables
      6.1.1. Microplates
      6.1.2. Cell Lines
      6.1.3. Reagents & Assay Kits
      6.1.4. Others
   6.2. Instruments
      6.3. Software
      6.4. Service
7. Global Cell Based Assays Market, By Application
   7.1. Drug Discovery
   7.2. Basic Research
   7.3. Predictive Toxicology
   7.4. Other Applications
8. Global Cell Based Assays Market, By End-Use Industry
   8.1. Pharmaceutical & Healthcare
   8.2. Government Institutions
   8.3. Others
9. Global Cell Based Assays Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Cell Based Assays – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles
   11.1. Becton, Dickinson and Company
      11.1.1. Introduction
      11.1.2. Financials
      11.1.3. Key Insights
      11.1.4. Key Strategy
      11.1.5. Product Portfolio
      11.1.6. SWOT Analysis
   11.2. General Electric Company
      11.2.1. Introduction
      11.2.2. Financials
      11.2.3. Key Insights
      11.2.4. Key Strategy
      11.2.5. Product Portfolio
      11.2.6. SWOT Analysis
   11.3. Thermo Fisher Scientific Inc      
      11.3.1. Introduction
      11.3.2. Financials
      11.3.3. Key Insights
      11.3.4. Key Strategy
      11.3.5. Product Portfolio
      11.3.6. SWOT Analysis
   11.4. Cell Signaling Technology, Inc.     
      11.4.1. Introduction
      11.4.2. Financials
      11.4.3. Key Insights
      11.4.4. Key Strategy
      11.4.5. Product Portfolio
      11.4.6. SWOT Analysis
   11.5. Danaher Corporation  
      11.5.1. Introduction
      11.5.2. Financials
      11.5.3. Key Insights
      11.5.4. Key Strategy
      11.5.5. Product Portfolio
      11.5.6. SWOT Analysis
   11.6. Cisbio Bioassays     
      11.6.1. Introduction
      11.6.2. Financials
      11.6.3. Key Insights
      11.6.4. Key Strategy
      11.6.5. Product Portfolio
      11.6.6. SWOT Analysis
   11.7. Danaher Corporation 
      11.7.1. Introduction
      11.7.2. Financials
      11.7.3. Key Insights
      11.7.4. Key Strategy
      11.7.5. Product Portfolio
      11.7.6. SWOT Analysis
   11.8. Promega Corporation     
      11.8.1. Introduction
      11.8.2. Financials
      11.8.3. Key Insights
      11.8.4. Key Strategy
      11.8.5. Product Portfolio
      11.8.6. SWOT Analysis
   11.9. Merck & Co., Inc. 
      11.9.1. Introduction
      11.9.2. Financials
      11.9.3. Key Insights
      11.9.4. Key Strategy
      11.9.5. Product Portfolio
      11.9.6. SWOT Analysis
   11.10. Perkinelmer, Inc.     
      11.10.1. Introduction
      11.10.2. Financials
      11.10.3. Key Insights
      11.10.4. Key Strategy
      11.10.5. Product Portfolio
      11.10.6. SWOT Analysis
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix

   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll